819 related articles for article (PubMed ID: 21976740)
41. Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome.
Aizawa-Yashiro T; Tsuruga K; Watanabe S; Oki E; Ito E; Tanaka H
Pediatr Nephrol; 2011 Aug; 26(8):1255-61. PubMed ID: 21479767
[TBL] [Abstract][Full Text] [Related]
42. Treatment of steroid resistant nephrotic syndrome in children.
Kari JA; Halawani M
Saudi J Kidney Dis Transpl; 2010 May; 21(3):484-7. PubMed ID: 20427873
[TBL] [Abstract][Full Text] [Related]
43. Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome.
Hamasaki Y; Yoshikawa N; Hattori S; Sasaki S; Iijima K; Nakanishi K; Matsuyama T; Ishikura K; Yata N; Kaneko T; Honda M;
Pediatr Nephrol; 2009 Nov; 24(11):2177-85. PubMed ID: 19714370
[TBL] [Abstract][Full Text] [Related]
44. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
[TBL] [Abstract][Full Text] [Related]
45. Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab.
Fujinaga S; Someya T; Watanabe T; Ito A; Ohtomo Y; Shimizu T; Kaneko K
Eur J Pediatr; 2013 Apr; 172(4):513-8. PubMed ID: 23271494
[TBL] [Abstract][Full Text] [Related]
46. Tacrolimus can induce remission in cyclosporine and mycophenolate mofetil resistant pediatric onset nephrotic syndrome.
Ahmed HM
Iran J Kidney Dis; 2019 Sep; 13(5):322-327. PubMed ID: 31705749
[TBL] [Abstract][Full Text] [Related]
47. Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome.
Afzal K; Bagga A; Menon S; Hari P; Jordan SC
Pediatr Nephrol; 2007 Dec; 22(12):2059-65. PubMed ID: 17938973
[TBL] [Abstract][Full Text] [Related]
48. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
Pham PT; Pham PC
Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
[TBL] [Abstract][Full Text] [Related]
49. [Long-term effects of cyclosporine A in children with steroid-resistant idiopathic nephrotic syndrome and outcomes of the patients].
Cao Q; Huang WY; Xu H; Zhou LJ
Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):698-701. PubMed ID: 19099862
[TBL] [Abstract][Full Text] [Related]
50. A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome.
Fujinaga S; Ohtomo Y; Umino D; Takemoto M; Shimizu T; Yamashiro Y; Kaneko K
Pediatr Nephrol; 2007 Jan; 22(1):71-6. PubMed ID: 17086405
[TBL] [Abstract][Full Text] [Related]
51. Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome.
El-Husseini A; El-Basuony F; Mahmoud I; Donia A; Sheashaa H; Sabry A; Hassan N; Sayed-Ahmad N; Sobh M
Eur J Clin Pharmacol; 2006 Jan; 62(1):3-8. PubMed ID: 16374637
[TBL] [Abstract][Full Text] [Related]
52. Focal segmental glomerulosclerosis in children.
Jellouli M; Abidi K; Askri M; Ferjani M; Naija O; Hammi Y; Goucha R; Gargah T
Tunis Med; 2016 May; 94(5):356-359. PubMed ID: 27801486
[TBL] [Abstract][Full Text] [Related]
53. Other immunosuppressive agents for focal segmental glomerulosclerosis.
Ponticelli C; Passerini P
Semin Nephrol; 2003 Mar; 23(2):242-8. PubMed ID: 12704585
[TBL] [Abstract][Full Text] [Related]
54. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.
Ulinski T; Dubourg L; Saïd MH; Parchoux B; Ranchin B; Cochat P
Pediatr Nephrol; 2005 Apr; 20(4):482-5. PubMed ID: 15719253
[TBL] [Abstract][Full Text] [Related]
55. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
[TBL] [Abstract][Full Text] [Related]
56. Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.
Büscher AK; Beck BB; Melk A; Hoefele J; Kranz B; Bamborschke D; Baig S; Lange-Sperandio B; Jungraithmayr T; Weber LT; Kemper MJ; Tönshoff B; Hoyer PF; Konrad M; Weber S;
Clin J Am Soc Nephrol; 2016 Feb; 11(2):245-53. PubMed ID: 26668027
[TBL] [Abstract][Full Text] [Related]
57. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children.
Inaba A; Hamasaki Y; Ishikura K; Hamada R; Sakai T; Hataya H; Komaki F; Kaneko T; Mori M; Honda M
Pediatr Nephrol; 2016 Mar; 31(3):425-34. PubMed ID: 26335197
[TBL] [Abstract][Full Text] [Related]
58. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
Hamed RM
J Nephrol; 1997; 10(5):266-70. PubMed ID: 9364319
[TBL] [Abstract][Full Text] [Related]
59. C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome.
Nakahata T; Tanaka H; Tsugawa K; Kudo M; Suzuki K; Ito E; Waga S
Clin Nephrol; 2005 Oct; 64(4):258-63. PubMed ID: 16240896
[TBL] [Abstract][Full Text] [Related]
60. Long-term results of cyclosporine-induced remission of relapsing nephrotic syndrome in children.
Kim PK; Kim KS; Pai KS; Kim JH; Choi IJ
Yonsei Med J; 1997 Oct; 38(5):307-18. PubMed ID: 9409194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
